![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Comorbid Conditions Associated with Decision-Making Regarding Treating or Not Treating Chronic Hepatitis C in a Large U.S. Health Maintenance Organization
|
|
|
Reported by Jules Levin
Digestive Disease Week, May 3-6, 2014, Chicago, IL
Lisa M. Nyberg1, Kevin M. Chiang2, Zhaoliang Li2, Anders H. Nyberg1, Zobair M. Younossi3, T. Craig Cheetham4
1Hepatology Research, Kaiser Permanente, San Diego, CA, USA; 2Pharmacy Analytical Services, Kaiser Permanente, Downey, CA, USA;
3Center for Liver Diseases, Dept. of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA; 4Kaiser Permanente, Department of Research and Evaluation, Pasadena, CA, USA
![DDW1.gif](../images/050614/050614-3/DDW1.gif)
![DDW2.gif](../images/050614/050614-3/DDW2.gif)
![DDW3.gif](../images/050614/050614-3/DDW3.gif)
![DDW4.gif](../images/050614/050614-3/DDW4.gif)
![DDW5.gif](../images/050614/050614-3/DDW5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|